Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Therabene
AddedFeb 17, 2024
UpdatedJun 18, 2026
Therabene

Therabene

Therabene, a Massachusetts-based biotech firm, develops targeted PROTAC molecules for cancer and autoimmune diseases, seeking strategic partnerships.

HQ
Mansfield, MA, US
Founded
2020
Overview
Compare
Fundraising
Employees
Website

Therabene, founded by Dr. Mario DiPaola, is a biotechnology company based in Mansfield, Massachusetts. The company’s core mission is to develop highly targeted PROTAC molecules to treat cancers, viral, and autoimmune diseases, aiming for better outcomes for patients and their families. Utilizing a blend of virtual screening, generative AI tools, and conventional lab practices, Therabene focuses on creating high-potency, low-toxicity therapeutics. Their market focus includes partnerships with academic and clinical research institutions, as well as pharmaceutical, biopharma, and biotech companies.

Notable figures associated with Therabene include its founder, Dr. Mario DiPaola, who brings over 25 years of experience in the biotech and pharmaceutical industries. The company is actively seeking strategic partnerships to advance its PROTAC molecule development. Key achievements include the successful integration of advanced AI tools in their drug discovery process, positioning them as a forward-thinking entity in the biotech sector. Therabene's impact lies in its innovative approach to developing targeted therapies that promise improved patient outcomes with reduced side effects.

Therabene - Similar Companies

Theracos logo

Theracos

theracos.com

Theradaptive logo

Theradaptive

theradaptive.com

Bien-Etre Labs logo

Bien-Etre Labs

Enable Therapeutics logo

Enable Therapeutics

Therabron Therapeutics logo

Therabron Therapeutics

therabron.com

Faze Medicines logo

Faze Medicines

fazemed.com

Therapyx logo

Therapyx

therapyxinc.com

Santi Therapeutics logo

Santi Therapeutics

Therabiol logo

Therabiol

PAQ Therapeutics logo

PAQ Therapeutics

paqtx.com

Therini Bio logo

Therini Bio

therinibio.com

TenSixty Biosciences logo

TenSixty Biosciences

tensixty.bio

ProThera Biologics logo

ProThera Biologics

Deep Apple Therapeutics logo

Deep Apple Therapeutics

deepappletx.com

ProFound Therapeutics logo

ProFound Therapeutics

profoundtx.com

Therabene - Quick Facts

Who are Therabene's competitors?

Companies similar to Therabene include Theracos, Theradaptive, Bien-Etre Labs and Enable Therapeutics.

When was Therabene founded?

Therabene was founded in 2020.

Where is Therabene's headquarters located?

Therabene's headquarters is located in Mansfield, MA, US.

When was Therabene's last funding round?

Therabene's most recent funding round was for $50k (USD) in October 2022.

How much has Therabene raised to-date?

As of Oct 11, 2022, Therabene has raised a total of $50k (USD).

How many employees does Therabene have?

Therabene has 5 employees as of Feb 5, 2024.

Therabene - Classification

Technology
  • AI
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Drug Discovery
  • Therapeutics
Tags
  • GenAI
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified